tradingkey.logo

Inotiv Inc

NOTV
0.418USD
+0.028+7.26%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
14.37MCap. mercado
PérdidaP/E TTM

Más Datos de Inotiv Inc Compañía

Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Información de Inotiv Inc

Símbolo de cotizaciónNOTV
Nombre de la empresaInotiv Inc
Fecha de salida a bolsaNov 25, 1997
Director ejecutivoLeasure (Robert W)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 25
Dirección2701 Kent Ave
CiudadWEST LAFAYETTE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal47906-1382
Teléfono13174634527
Sitio Webhttps://www.inotiv.com/
Símbolo de cotizaciónNOTV
Fecha de salida a bolsaNov 25, 1997
Director ejecutivoLeasure (Robert W)

Ejecutivos de Inotiv Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
694.19K
-14125.00%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
378.73K
-22048.00%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+25000.00%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
104.93K
+27500.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
76.89K
+27500.00%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
19.00K
-36000.00%
Mr. R. Matthew Neff
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Beth A. Taylor
Ms. Beth A. Taylor
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Mr. David Landman
Mr. David Landman
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
694.19K
-14125.00%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
378.73K
-22048.00%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+25000.00%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
104.93K
+27500.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
76.89K
+27500.00%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
19.00K
-36000.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
447.98M
87.32%
Netherlands
35.48M
6.92%
Other
29.56M
5.76%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: mié., 4 de feb
Actualizado: mié., 4 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
4.04%
Leasure (Robert Jr.)
3.55%
Balyasny Asset Management LP
2.87%
Sagartz (John E)
2.02%
GSA Capital Partners LLP
1.48%
Otro
86.05%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
4.04%
Leasure (Robert Jr.)
3.55%
Balyasny Asset Management LP
2.87%
Sagartz (John E)
2.02%
GSA Capital Partners LLP
1.48%
Otro
86.05%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
9.93%
Individual Investor
9.65%
Hedge Fund
6.87%
Investment Advisor/Hedge Fund
4.67%
Corporation
3.66%
Research Firm
2.33%
Venture Capital
0.33%
Bank and Trust
0.14%
Private Equity
0.06%
Otro
62.35%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
168
8.26M
24.01%
-3.92M
2025Q3
173
8.82M
25.69%
-3.41M
2025Q2
195
12.88M
37.49%
-4.07M
2025Q1
224
12.80M
37.26%
-4.48M
2024Q4
233
12.65M
38.89%
+1.31M
2024Q3
250
7.31M
26.57%
-8.16M
2024Q2
259
7.59M
28.13%
-9.62M
2024Q1
274
9.86M
38.07%
-7.14M
2023Q4
278
8.23M
31.98%
-10.32M
2023Q3
287
9.98M
38.79%
-9.73M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
1.40M
4.09%
+20.89K
+1.51%
Sep 30, 2025
Leasure (Robert Jr.)
1.24M
3.61%
+429.73K
+52.90%
Mar 14, 2025
Balyasny Asset Management LP
985.74K
2.87%
-668.91K
-40.43%
Sep 30, 2025
Sagartz (John E)
708.32K
2.06%
+30.00K
+4.42%
Mar 14, 2025
GSA Capital Partners LLP
234.52K
0.68%
+234.52K
--
Sep 30, 2025
UBS Financial Services, Inc.
314.55K
0.92%
+36.34K
+13.06%
Sep 30, 2025
Hardy (Adrian)
400.78K
1.17%
+25.00K
+6.65%
Mar 14, 2025
Renaissance Technologies LLC
359.76K
1.05%
-38.19K
-9.60%
Sep 30, 2025
Massar Capital Management, LP
350.00K
1.02%
--
--
Sep 30, 2025
Vantage Point Financial, LLC.
336.55K
0.98%
--
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
Avantis US Small Cap Value ETF
0%
Avantis US Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proporción0.01%
Dimensional US Core Equity 1 ETF
Proporción0%
DFA Dimensional US Core Equity Market ETF
Proporción0%
Avantis US Small Cap Value ETF
Proporción0%
Avantis US Equity ETF
Proporción0%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0%
Avantis US Small Cap Equity ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI